The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

In D’Iberville, those battling Parkinson’s Disease are slipping on the gloves and fighting back thanks to SAAD Healthcare’s Rock Steady Boxing classes.

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive outlook.

"Depression and apathy are two of the most difficult symptoms of the disease ... fighting Parkinson's his full-time job one step at a time. "You have to look this thing in the eye and say ...

New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...

Hearing impairment has emerged as a potential risk factor for Parkinson’s disease, a progressive neurodegenerative disorder that primarily manifests with motor impairments like tremors, rigidity, and ...

Studying the symptom experience of persons with Parkinson's disease (PD) could aid in determining the extent to which particular symptoms and symptom dimensions pose a problem and could assist in ...

Excessive screen time is an unavoidable part of many modern jobs But prolonged screen use can impact physical health, mental well-being and productivity Common issues include eye strain ...